Skip to content

The Effect of Prednisone on Physical Exercise in COPD Patients

The Effect of Prednisone and Solu-Medrol on Physical Exercise in COPD Patients and the Inflammaroty Response During and After Exercis.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01978665
Acronym
COPDpred
Enrollment
14
Registered
2013-11-07
Start date
2013-04-30
Completion date
2013-12-31
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Performance in Copd Patients

Keywords

COPD exercise inflammation prednisone

Brief summary

The objective of this study is to investigate if there is an effect on exercise performance og of the anti inflammatory drugs prednisone and solu-medrol in patints with chronic obstructive pulmonary disease(COPD)

Detailed description

RCT study with 4 days of steroid

Interventions

DRUGprednisone

similar size tablets

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Intervention model description

RCT study with steroid.

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

FEV1\< 60% FEV1/FVC ratio \<70 % * able to use a ergometer bike

Exclusion criteria

Haemodynamicaly unstable heart conditions * exacerbations before 6 week entry of the study exacerbation during the study period treatment with beta blockers malignancy the last 5 years allergi toward IMP

Design outcomes

Primary

MeasureTime frameDescription
effect on muscle powerjan 2013 to july 2013 (6 months)muscular strenght

Secondary

MeasureTime frameDescription
the inflammatory responsejan 2013 to july 2013 (6 months)hsCRP

Other

MeasureTime frameDescription
vo2maxjan 2013 to july 2013 ( 6 months)fitness
VO2maxjan 2013 until july 2013 (6 months)fitness

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026